Skip to main content
. Author manuscript; available in PMC: 2021 Nov 2.
Published in final edited form as: Nat Med. 2019 Jun 6;25(6):936–940. doi: 10.1038/s41591-019-0476-5

Extended Data Fig. 1 |. Pharmacokinetic concentration-time profiles of pembrolizumab, dabrafenib and trametinib.

Extended Data Fig. 1 |

Pharmacokinetic concentration-time profiles of (a) pembrolizumab, (b) dabrafenib and (c) trametinib following administration of 2 mg/kg pembrolizumab intravenously administered together with multiple oral administrations dabrafenib 150 mg twice daily and trametinib 2 mg daily. Individual concentrations/profiles are presented as colored lines for pembrolizumab and open circles for dabrafenib and trametinib. Arithmetic mean concentration-time profiles (±standard error) are presented as dotted black bold lines.